Perrigo FY 1995 sales increase 7% to $717.1 mil., following 10% gain in fourth quarter.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO FY 1995 SALES INCREASE 7.1% TO $717.1 MIL. for the year ended June 30. Sales in the fourth quarter rose 10% to $174.4 mil. As expected, the company's analgesic sales continued to be soft into the final quarter, Perrigo noted. The company has cited increased competition in the analgesics market due, in part, to Procter & Gamble's launch of Aleve as well as a mild cold and flu season as negatively affecting its sales